Ladarixin Uses, Dosage, Side Effects and more

Ladarixin is under investigation in clinical trial NCT04628481 (A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual Β-Cell Function).

Trade Name Ladarixin
Generic Ladarixin
Ladarixin Other Names Ladarixin
Type
Formula C11H12F3NO6S2
Weight Average: 375.33
Monoisotopic: 375.005813947
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share